Imunon(GB:0HUZ)
$11.480.00 (0.00%)
GB:0HUZ
Imunon financials statements
$11.48
At close:0.00 (0.00%)
Imunon (0HUZ) Ratios
2 Followers
Imunon Ratios
GB:0HUZ's free cash flow for Q3 2026 was $-3.20M. For the 2026 fiscal year, GB:0HUZ's free cash flow was decreased by $-1.79K and operating cash flow was $-3.20M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.32 | 1.67 | 2.47 | 3.66 | 7.67 |
| Quick Ratio | 2.32 | 1.67 | 2.47 | 3.66 | 7.67 |
| Cash Ratio | 1.90 | 1.23 | 0.79 | 1.15 | 2.89 |
| Solvency Ratio | -2.64 | -3.27 | -2.20 | -2.40 | -1.10 |
| Operating Cash Flow Ratio | -3.01 | -3.94 | -2.57 | -2.30 | -2.40 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -16.21 | 0.00 |
| Net Current Asset Value | $ 5.50M | $ 2.54M | $ 9.71M | $ 22.13M | $ 33.69M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.12 | 0.07 | 0.14 | 0.09 |
| Debt-to-Equity Ratio | 0.14 | 0.27 | 0.12 | 0.21 | 0.12 |
| Debt-to-Capital Ratio | 0.12 | 0.21 | 0.11 | 0.18 | 0.11 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.00 | 0.00 | 0.14 | 0.09 |
| Financial Leverage Ratio | 1.74 | 2.29 | 1.64 | 1.50 | 1.33 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | -94.37 | -4.67 | -34.21 |
| Interest Coverage Ratio | 0.00 | 0.00 | -106.71 | -4.96 | -36.86 |
| Debt to Market Cap | 0.07 | 0.00 | 0.00 | 0.54 | 1.74 |
| Interest Debt Per Share | 0.47 | 1.29 | 2.63 | 20.63 | 259.72 |
| Net Debt to EBITDA | 0.56 | 0.26 | 0.21 | 0.16 | 0.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | -6487.33% | -4316.56% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | -6341.00% | -4175.98% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | -4984.31% | -4201.44% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | -7493.05% | -4430.54% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | -7179.65% | -4153.85% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | -7179.65% | -4153.85% |
| Net Income Per EBT | 100.00% | 100.00% | 93.84% | 95.82% | 93.75% |
| EBT Per EBIT | 98.94% | 97.32% | 98.88% | 150.33% | 105.45% |
| Return on Assets (ROA) | -117.96% | -191.62% | -89.04% | -81.63% | -28.05% |
| Return on Equity (ROE) | -205.25% | -438.71% | -145.77% | -122.40% | -37.22% |
| Return on Capital Employed (ROCE) | -191.16% | -387.99% | -144.77% | -73.43% | -31.22% |
| Return on Invested Capital (ROIC) | -181.53% | -355.38% | -131.46% | -67.09% | -29.04% |
| Return on Tangible Assets | -117.96% | -191.62% | -89.04% | -81.63% | -34.23% |
| Earnings Yield | -179.20% | -148.10% | -275.89% | -323.72% | -616.29% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 3.88 | 4.59 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.71 | 0.43 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 94.12 | 79.46 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 94.12 | 79.46 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 94.12 | 79.46 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -6.55 | -21.37 | -27.43 | -42.18 | -584.91 |
| Free Cash Flow Per Share | -6.68 | -21.40 | -28.08 | -42.67 | -596.14 |
| Dividend Paid and CapEx Coverage Ratio | -47.78 | -638.26 | -42.11 | -86.25 | -52.06 |
| Capital Expenditure Coverage Ratio | -49.53 | -638.26 | -42.11 | -86.25 | -52.06 |
| Operating Cash Flow Coverage Ratio | -13.79 | -16.55 | -11.71 | -3.69 | -2.45 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | -46.19 | -32.45 |
| Free Cash Flow Yield | -175.27% | -150.20% | -275.31% | -210.69% | -490.65% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.56 | -0.68 | -0.36 | -0.31 | -0.16 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 22.18 | 6.74 |
| Price-to-Book (P/B) Ratio | 1.15 | 2.96 | 0.53 | 0.38 | 0.06 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.57 | -0.67 | -0.36 | -0.47 | -0.20 |
| Price-to-Operating Cash Flow Ratio | -0.58 | -0.67 | -0.37 | -0.48 | -0.21 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.03 | 0.01 | 0.00 | -0.00 |
| Enterprise Value Multiple | -0.02 | -0.44 | -0.14 | -0.18 | 0.46 |
| Enterprise Value | 315.63K | 7.84M | 2.86M | 5.86M | -9.58M |
| EV to EBITDA | -0.02 | -0.44 | -0.14 | -0.18 | 0.46 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 11.73 | -19.16 |
| EV to Free Cash Flow | -0.02 | -0.42 | -0.15 | -0.25 | 0.58 |
| EV to Operating Cash Flow | -0.02 | -0.42 | -0.15 | -0.25 | 0.59 |
| Tangible Book Value Per Share | 3.33 | 4.81 | 19.31 | 53.55 | 1529.71 |
| Shareholders’ Equity Per Share | 3.33 | 4.81 | 19.31 | 53.55 | 2011.61 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.06 | 0.04 | 0.06 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.91 | 18.03 |
| Net Income Per Share | -6.83 | -21.10 | -28.14 | -65.55 | -748.79 |
| Tax Burden | 1.00 | 1.00 | 0.94 | 0.96 | 0.94 |
| Interest Burden | 1.00 | 1.00 | 1.01 | 1.16 | 1.03 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 23.47 | 21.24 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 27.38 | 21.78 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 5.35 | 7.52 |
| Income Quality | 0.96 | 1.01 | 0.97 | 0.64 | 0.78 |
Currency in USD
